Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Contact Us

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO >

Sun Pharmaceutical Industries Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	524715
ISIN Demat	INE044A01036
Book Value	104.58

NSE Code	SUNPHARMA
Dividend Yield %	1.01
Market Cap	3789989.52

P/E	78.99
EPS	20.00
Face Value	1


	BSE		NSE

03-Sep-2025

Last Price	1579.60
Net Change	15.05
% Change	0.96%
Prev.Close	1564.55
Open	1569.60
High	1580.80
Low	1558.70
Volume	23589

Last Price	1578.70
Net Change	13.5
% Change	0.86%
Prev.Close	1565.20
Open	1562.10
High	1581.10
Low	1558.30
Volume	2091370

Value	37079042
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1580.80
52-Week High	1960.20
52-Week Low	1555.00

Value	3288999359.4
Best Buy	0.00
Best Sell	1578.70
Best Quantity	0
Sell Quantity	254
Today's Range	1581.10
52-Week High	1960.35
52-Week Low	1553.05

Open Price	1562.70
High Price	1586.50
Low Price	1562.70
Last Price	1583.60
Prev Close	1569.50
Change	14.10
% Change	0.90 %

Average Price	1580.00
Underlying Value	1578.70
Number of contracts traded	6101
Turnover in Rs. Lakhs	33739
Open Interest	14908950.00
Change in O I	263200.00
% Change in O I	1.80 %

Today

|

1W

|

1M

|

1Y

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	254
Price	1578.70

Best Bid

Best Offer

Quantity	350
Price	1583.7

Quantity	700
Price	1584.4

Holding Details

Latest Corporate Events

Bonus

1 : 1

29-Jul-13

Book Closure

25-Aug-21

31-Aug-21

Dividend

550 %

07-Jul-25

Company News

04-08-2025

Sun Pharmaceutical Indust...

01-08-2025

Clarification sought fro...

31-07-2025

Sun Pharmaceutical Indust...

21-07-2025

Sun Pharmaceutical Indus...

18-07-2025

Sun Pharma incorporates s...

15-07-2025

Sun Pharmaceutical Indust...

15-07-2025

Sun Pharmaceutical Indust...

Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.